Thomas Buchholz
About Thomas Buchholz
Thomas Buchholz is the Chief Scientific Officer at Scripps Health and serves on multiple boards, including Bucknell University and Empyrean Medical Systems. He has a distinguished career in oncology and has held significant roles at MD Anderson Cancer Center and the United States Air Force.
Chief Scientific Officer at Scripps Health
Thomas Buchholz currently serves as Chief Scientific Officer at Scripps Health. In this role, he focuses on the development of clinical research activities within the Scripps MD Anderson Cancer Center. He also serves as Corporate Senior Vice President and Medical Director, ensuring the organization remains at the forefront of oncology research and treatment.
Board Memberships
Thomas Buchholz holds multiple board positions. He serves on the Board of Trustees at Bucknell University in Lewisburg, Pennsylvania, and on the boards of Empyrean Medical Systems and Nucleix Ltd. He also contributes to the Rancho Sante Fe Foundation. His roles on these boards are pivotal in guiding organizational strategy and governance.
Previous Roles at MD Anderson Cancer Center
Thomas Buchholz has a substantial history at MD Anderson Cancer Center, holding several key positions. From 2014 to 2017, he was Executive Vice President and Physician in Chief. Prior to that, he served as Provost and Executive Vice President from 2012 to 2014, Division Head and Department Chair of Radiation Oncology from 2007 to 2012, and Assistant Professor to tenured Professor from 1997 to 2012.
Educational Background
Thomas Buchholz earned his Doctor of Medicine (MD) from Tufts University School of Medicine, graduating in 1988. He completed his residency in Radiation Oncology at the University of Washington - School of Medicine in 1993. He also holds a Bachelor of Arts (BA) in Philosophy from Bucknell University, achieved in 1984.
Military Service
From 1993 to 1997, Thomas Buchholz served as a Major and Radiation Oncologist in the United States Air Force. During his tenure, he contributed significantly to the field of radiation oncology within a military context. This experience provided him with a unique perspective on medical practice and leadership.